Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR AI

Date Submitted: Feb 11, 2025
Date Accepted: Jan 18, 2026

The final, peer-reviewed published version of this preprint can be found here:

In Silico Evaluation of Algorithm-Based Clinical Decision Support Systems Based on Care Pathway Simulation Models: Scoping Review

Dorosan M, Chen YL, He Y, Zhuang Q, Lam SWS

In Silico Evaluation of Algorithm-Based Clinical Decision Support Systems Based on Care Pathway Simulation Models: Scoping Review

JMIR AI 2026;5:e72472

DOI: 10.2196/72472

PMID: 41875209

PMCID: 13012236

In silico evaluation of algorithm-based clinical decision support systems based on care pathway simulation models: A scoping review

  • Michael Dorosan; 
  • Ya-Lin Chen; 
  • Yan He; 
  • Qingyuan Zhuang; 
  • Shao Wei Sean Lam

ABSTRACT

Background:

In silico evaluation (ISE) methods create a digital twin or a computer simulation of actual care pathways, enabling a broader assessment of the potential impact of algorithm-based clinical decision support systems (CDSS) prior to implementation.

Objective:

This study aims to review the scope of proposed ISE methods to evaluate CDSS. Specifically, it focuses on simulation modeling methods, paradigms, parameters, and outcomes considered within the ISE methodological domain.

Methods:

The current review follows widely accepted scoping review guidelines. We conceptualized our search framework and conducted a two-stage screening process of studies collected using an automated search of selected databases. Subsequently, information about CDSS and simulation modeling methods was extracted.

Results:

Our review revealed that a small subset of studies on CDSS development conducted validation studies that leveraged clinical workflow simulations. Existing studies frequently prioritize patient, process, and cost-effectiveness outcomes, while the outcomes directly related to the care providers’ well-being are lacking. Studies reviewed demonstrated a diverse collection of simulation modeling paradigms. These included discrete event simulation, agent-based modeling, and Markov modeling. Three distinct ISE objectives surfaced from the reviewed literature: (1) outcome comparison; (2) outcome comparison with sensitivity analysis, and (3) simulation-based optimization. The first two implement a decoupled CDSS model training followed by simulation-based evaluation of the trained CDSS model. The third approach simultaneously optimizes the CDSS model decision support capabilities through the simulation process, where training and evaluation take place simultaneously.

Conclusions:

The growing body of research in the development of algorithm-based CDSS calls for a shift in how evidence for their safety and reliability can be ascertained. Traditional trial-based evaluations may not align with the risk considerations and resource impact of novel algorithm-based CDSS without a compelling understanding of systems-level implications in clinical workflows. Our review examined the potential and gaps of ISE, particularly through simulation modeling, which can be applied as a pre-implementation strategy to reinforce evidence for safe and effective implementation of algorithm-based CDSS.


 Citation

Please cite as:

Dorosan M, Chen YL, He Y, Zhuang Q, Lam SWS

In Silico Evaluation of Algorithm-Based Clinical Decision Support Systems Based on Care Pathway Simulation Models: Scoping Review

JMIR AI 2026;5:e72472

DOI: 10.2196/72472

PMID: 41875209

PMCID: 13012236

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.